Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks

Area of Science:

• Physiology
• Altitude Adaptation
• Cardiovascular Research

Background:

• High altitude pulmonary hypertension is a significant health concern.
• Asymmetric dimethylarginine (ADMA) inhibits nitric oxide (NO) synthesis and is linked to adverse outcomes in pulmonary hypertension.
• The regulation of the ADMA-NO pathway in high-altitude adapted animals remains largely unexplored.

Purpose of the Study:

• To investigate the regulation of the ADMA-NO pathway in yaks, animals adapted to high altitudes.
• To determine plasma ADMA concentrations, eNOS, DDAH protein expression, and DDAH activities in yak lungs.
• To elucidate the mechanisms underlying normal pulmonary arterial pressure in hypoxemic yaks.

Main Methods:

• Measurement of plasma ADMA concentration in yaks.
• Assessment of endothelial NO synthase (eNOS) and dimethylarginine dimethylaminohydrolases (DDAH) protein expression in yak lungs.
• Determination of DDAH activities in lung tissue from yaks.

Main Results:

• Yaks, despite hypoxemia, maintained near-normal cardiac function and pulmonary arterial pressures.
• Decreased DDAH expression and activity were observed in yak lungs, correlating with reduced plasma ADMA concentrations.
• Significantly higher eNOS expression was found in yaks compared to controls (implied).

Conclusions:

• Augmented endogenous NO activity, mediated by the ADMA-DDAH pathway and eNOS upregulation, contributes to low pulmonary vascular tone in high-altitude adapted yaks.
• These findings provide insights into the physiological adaptations that protect against high altitude pulmonary hypertension.
• The study highlights a novel mechanism of NO regulation in animals thriving at extreme altitudes.